SPRINGFIELD, Va. The Drug Enforcement Agency on Friday classified boldione, desoxymethyltestosterone and 19-nor-4,9(10)-androstadienedione as “anabolic steroids” under the Controlled Substances Act, in accordance with authority afforded the DEA by the Anabolic Steroid Control Act of 2004. Any supplier illegally marketing these steroids as supplements now will be subject to DEA prosecution in addition to prosecution from the Food and Drug Administration.
"While this was the DEA’s first action under the 2004 law, we hope it will not be the last,” stated John Gay, executive director and CEO of the Natural Products Association. "As [NPA] stated at the Senate Judiciary Committee hearing in September on enforcement barriers affecting body-building products and hidden steroids, the DEA anticipates that after these first steroids are scheduled it will be easier to follow up with more enforcement and in greater frequency. The Natural Products Association looks forward to working with the agencies as they use this ability to schedule any anabolic steroids that are masquerading as supplements."